key: cord-0687973-aa4864j8
authors: Siebach, Melissa K.; Piedimonte, Giovanni; Ley, Sylvia H.
title: COVID‐19 in childhood: Transmission, clinical presentation, complications and risk factors
date: 2021-03-15
journal: Pediatr Pulmonol
DOI: 10.1002/ppul.25344
sha: 699449fe4af2b2180729bfa33f2f2f5a97ce7a7d
doc_id: 687973
cord_uid: aa4864j8

Children less than 18 years of age account for an estimated 2%–5% of reported severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) cases globally. Lower prevalence of coronavirus disease 2019 (COVID‐19) among children, in addition to higher numbers of mild and asymptomatic cases, continues to provide challenges in determining appropriate prevention and treatment courses. Here, we summarize the current evidence on the transmission, clinical presentation, complications and risk factors in regard to SARS‐CoV‐2 in children, and highlight crucial gaps in knowledge going forward. Based on current evidence, children are rarely the primary source of secondary transmission in the household or in child care and school settings and are more likely to contract the virus from an adult household member. Higher transmission rates are observed in older children (10–19 years old) compared with younger children ( <10 years old). While increasing incidence of COVID‐19 in neonates raises the suspicion of vertical transmission, it is unlikely that breast milk is a vehicle for transmission from mother to infant. The vast majority of clinical cases of COVID‐19 in children are mild, but there are rare cases that have developed complications such as multisystem inflammatory syndrome in children, which often presents with severe cardiac symptoms requiring intensive care. Childhood obesity is associated with a higher risk of infection and a more severe clinical presentation. Although immediate mortality rates among children are low, long‐term respiratory, and developmental implications of the disease remain unknown in this young and vulnerable population.

the clinical course is generally milder and outcomes are better in children. 5 

According to the WHO, 6 SARS-CoV-2 is transmitted directly and indirectly through the respiratory secretions of those infected. Several studies have also looked at the prevalence and implications of fecal viral shedding in the pediatric population and the implications for transmission. 7 Based on a systematic review of contact tracing programs and population studies, the susceptibility of children to COVID-19 was lower than adults, although the role that they played in transmission was not conclusive. 8 The prominence of mild and asymptomatic illness in pediatric patients has created concern that the true prevalence of disease in this age group has been underreported. 4, 5 Population-based seroprevalence studies have had conflicting results. [9] [10] [11] The seroprevalence of antibodies in children was consistent with that of adults in the same area in the UK, 9 implying that children and adults are equally susceptible to the virus, however, in Italy seroprevalence increased with age. 11 Similar to reports in the adult population, racial, and socioeconomic disparities have also been noted among pediatric populations with studies noting higher rates of transmission among racial and/or ethnic minority groups 12 with more severe health outcomes. 13 2.1.1 | Household transmission Table 1 presents transmission sources as reported in several pediatric studies. Available data indicate that SARS-CoV-2-positive adults living in the household are the primary source of infection for children. It should be noted that shelter-in-place orders decreased outdoor activities in most countries and likely led to the increase of viral spread within households. 14 In an investigation of 110 cases stemming from 11 infection clusters in Japan, close contact in an indoor setting contributed to all 11 clusters. 15 In South Korea, household cases were the primary source of infection until mid-March, 2020, when imported cases became the most prevalent. 4 In the UK, a population-based seroprevalence study of children reported that neither age nor gender had any association with positive results, but contact with a household member with confirmed COVID-19 was a significant predictor for seropositivity. 9 Although children are usually infected by SARS-CoV-2-positive adults living in the household, several studies have shown that the overall risk of contagion to children is lower than that of other adults residing in the same household. 14, 23 In a meta-analysis looking at secondary attack rates (SAR) in the household setting (n = 54 studies), 14 the overall estimated SAR for household contacts was 16.6%, while that of close contacts was just 4.8%. Spouses of infected individuals were at greater risk than other household members (37.8% vs. 17.8%), whereas the rate of secondary household transmission to children was significantly lower than adults (16.8% vs. 28.3%). 14 A child's age may also affect the risk of transmission. In South Korea, analysis of data for 59,000 contacts of 5700 index cases found that a total of 11.8% of household contacts tested positive for COVID-19. 24 When further stratified by age, the infection rate was 18.6% for index cases aged 10-19 years, and 5.3% for ages 0-9 years. 24 Consistently, in a study of Swiss students, the seroprevalence of SARS-CoV-2 antibodies decreased with age. 10 

Vertical transmission was demonstrated with SARS-CoV-1, and the same risk theoretically exists for SARS-CoV-2, as the viral receptor (angiotensin-converting enzyme 2 [ACE-2]) is widely expressed in the placenta. 25 Although a systematic review of 18 studies (n = 157 mothers and 160 neonates) found no evidence of vertical transmission, 26 the growing number of confirmed neonatal cases of COVID-19 infection has reinforced the suspicion that SARS-CoV-2 is similarly capable of crossing the placenta to infect fetal lungs. A recent study identified three neonates delivered from COVID-positive mothers with pneumonia on chest radiography (CXR) obtained at birth and nasopharyngeal (NP) swabs positive for SARS-CoV-2 on Days 2 and 4 of life and negative on Day 6-7. 27 One of these patients was born at 31 weeks of gestation via cesarean delivery due to fetal distress and required resuscitation. Although vertical transmission was not found in several other neonates born to COVID-19 infected mothers, it is critical to note that most of such data have been limited by extremely small sample size SIEBACH ET AL.

| 1343 (frequently n = 1), a lack of cord blood or amniotic fluid evidence (the gold standard to prove vertical transmission), and provide little or no information on the outcome of the infants. A more recent systematic review (n = 205 infants of COVID-positive mothers) found that while vertical transmission of COVID-19 is unlikely, antibodies against SARS-CoV-2 were found in 10/11 (90%) infants who were tested. 28 As pregnant women are more susceptible than the general population to respiratory pathogens including COVID-19, maternal infection and inflammation in response to the virus could affect the developing fetus and even postnatal life. With the continuing pandemic of COVID-19, there is general consensus further studies are warranted to investigate pregnant women with COVID-19, follow-up the pregnancy outcomes, and monitor postnatal development of the fetus.

Based on the earliest 13 case studies/series (n = 48 milk samples from 32 women combined), only one sample contained virus, while SARS-CoV-2 antibodies were found in two other samples. 29 However, the sample collection and analytical methods were not provided in detail in these case reports, raising questions on methodological quality and potential for contamination. In a longitudinal study of two COVID-19 positive mothers following delivery (Day 0), the first mother's samples were all negative for SARS-CoV-2 RNA, but milk samples from days 10, 12, and 13 postdelivery were positive for the second mother. 30 The positive milk samples coincided with mild symptoms in the second mother and her infant tested positive for COVID-19 on Day 11. The first infant also tested positive for COVID-19, although viral RNA was absent in the first mother's samples. 30 In another study (n = 64 breastmilk samples from 18 COVID-19 positive mothers) viral RNA was isolated in one sample, but no replication-competent virus was detected. 31 Both breastmilk samples (n = 37 milk samples) and breast swabs (n = 70 swabs collected before and after cleaning the breast with soap and water before feeding) were analyzed from 18 COVID-19positive women. 32 SARS-CoV-2 RNA was not present in the milk samples, but was present on one of the pre-cleaning swabs. Furthermore, SARS-CoV-2 antibodies were detected in all 37 milk samples. 32 In addition, a systematic review of 37 studies (n = 77 infants of COVIDpositive mothers) found no evidence of SARS-CoV-2 transmission. 33 As SARS-CoV-2 transmission through breastmilk is unlikely, both the World Health Organization (WHO) and UNICEF currently recommend mothers with suspected or confirmed COVID-19 initiate or continue breastfeeding while following guidance on hygiene and mask use. 34, 35 For situations requiring donor milk, pasteurization of human milk by the Holder method (62.5°C for 30 min) inactivates SARS-CoV-2. 36 Table 2 provides data from studies analyzing secondary transmission of SARS-CoV-2 in the school setting. In South Korea, children were not the primary source of transmission within schools, as secondary cases were all a result of contact with an infected staff member. 39 In England, staff had higher incidence rates than students and accounted for most cases linked to outbreaks. 40 In Ireland, no secondary transmission of COVID-19 was reported in a follow-up of 1025 exposed school contacts. 41 These exposures included activities such as music lessons and choir practice, both of which are assumed to be high-risk activities for transmission. 41 Of 18 cases of secondary transmission in Australia, five cases occurred in three schools and the other 13 occurred in a single early childhood education center where the cluster outbreak was traced to a single adult staff member. 42 The overall child-to-child SAR was 0.3% (2/649) and the child to staff SAR was 1.0% (1/103), while the staff-to-staff SAR was 4.4% (7/160) and the staff-to-child SAR was 1.5% (8/536). 42 In Switzerland, researchers randomly analyzed seroprevalence among 2585 students (6-16 years old) in 55 schools and found that at least one seropositive case was reported in 36/55 schools with no evidence of clustered outbreaks or secondary transmission. 10 In Hong Kong, only 5 of 20 cases in children (5-17 years old) were associated with two clustered school outbreaks. 43 In Germany, 137

COVID-19-positive students attended school for at least one day while infectious. 44 Only six of these cases contributed to the transmission of SARS-CoV-2 to an additional 11 students. No additional secondary transmission was reported despite extensive screening and monitoring of more than 2300 close school contacts. 44 Abbreviations: ECEC, early childhood education and care centers; SAR, secondary attack rate; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. a Author did not specify the type of schools at which the adult staff members worked. Also, no clarification was made about whether more than one of the six cases was present in a single school. b 1025 contacts were monitored, symptomatic individuals were referred for testing, but exact numbers are unknown ± ECEC: early childhood education and care centers. Account for daycare, preschool and after-school care programs.

setting was uncommon and not the primary source of SARS-CoV-2 infection in children. 44 Ten days after schools reopened in Jerusalem in May, 2020, two separate cases of COVID-19 in the same high-school led to the infection of almost 260 people. 47 Within the school community, 153 students and 25 staff members were infected. Overly crowded classrooms without appropriate social distancing and the suspension of mask-wearing for several days in response to a heat wave likely contributed to the outbreak. 47 School infections peaked in Victoria, Australia, when community transmission was high, but transmission among children was not school driven. 48 Controlling community incidence is likely an effective means of controlling transmission within the educational setting. 40 In Sweden and Finland, the cumulative incidence rates of Children do not appear to be the primary drivers of SARS-CoV-2 transmission in the home or school settings and often present with mild or asymptomatic cases when infected. Table 3 summarizes 12 studies reporting clinical data of children with diagnosed or suspected COVID-19. 5 The heterogeneity in study participant selection criteria must be noted among these studies, which may have affected both clinical presentation and severity of the cases reported.

In a systematic review of literature regarding the clinical presentation of COVID-19 in children, the most commonly reported symptoms were fever and cough. 54 In a cohort study involving 651 pediatric cases in the UK, fever and a runny nose were more common in younger children, while vomiting, abdominal pain, headache and a sore throat showed an increasing trend with age. 50 Older children were more likely to present with respiratory distress than infants (44% vs. 7%). 17 Less common symptoms include seizures 16 In Turkey, of 220 positive pediatric cases, 145 (70.5%) were classified as asymptomatic (25.5%) or mild (45%). 19 In South Korea, 22%

of COVID-19-positive study participants remained asymptomatic throughout a 3-week monitoring period. 4 A systematic review of studies (n = 4300 confirmed pediatric cases) reported that 18.9% of children were asymptomatic. 55 The majority of studies reported a mortality rate of less than 2% (Table 3) .

There is a significant difference in the median age between studies, with the lowest being 2.3 years old 16 and the highest 13 years. 51 Infants (aged < 1 year) account for between 30% and 40% of participants in half of the studies ( Table 3 ). The high proportion of infants could be influenced by a tendency for parents to seek medical attention for this age group and an increased likelihood that physicians will admit them to hospitals. 16 A multivariate analysis reported an association between neonatal period ( <1 month of age) and ICU admission (odd ratio 5.06). 18, 50 Several studies noted that COVID-19 positive patients had elevated blood markers indicative of inflammation. 17, 19, 50, 51, 53 One study reported that 38.8% (47/121) of participants had high concentrations of the inflammatory marker C-reactive protein (CRP). 16 Moreover, children with more serious symptoms were found to have significantly higher CRP levels than those with a milder presentation. 17 In Turkey, lymphopenia was the most common abnormal lab value found amongst participants (13.5%; 85/220). 19 While COVID-19 in children can present with a variety of symptoms, pediatric cases are most often mild or asymptomatic. In Toxic Shock Syndrome (TSS), particularly the elevation of multiple inflammatory markers with severe cardiac involvement. 50, 56, [59] [60] [61] [62] In the UK, MIS-C is referred to as pediatric inflammatory multisystem syndrome temporarily associated with SARS-CoV-2 (PIMS-TS). 63 Later, as the medical and scientific community became aware of MIS-C as a distinct condition, more formal diagnostic characteristics were sought. 64 Since then, the WHO, 65 (Table 4) , although a combination of these symptoms must be present in order for patients to meet the case definition for MIS-C or PIMS-TS. 64 13 (87) 13 (87) 14 (93) (20) 4 (2) Verdoni et al. 60 (Italy) c Value includes participants who tested positive for SARS-CoV-2 antibodies.

Though pediatric mortality rates are low, even among those diagnosed with MIS-C, there continues to be significant concern regarding which, if any, comorbidities place children at increased risk for COVID-19 infection.

Obesity, chronic respiratory diseases (particularly asthma), and a compromised or suppressed immune system are the most common underlying medical conditions that have been cited. Table 5 summarizes 12 studies that have included comorbidity data.

Obesity was the most common comorbidity among hospitalized COVID-positive children, with a significant association between obesity and severe cases requiring mechanical ventilation in children 2 years and older. 17 A retrospective study from Wuhan, China reported that an elevated body mass index (BMI) was correlated with an increased mortality risk in COVID-19 patients aged years. 79 In another study, 30% (14/46) of admitted pediatric patients testing positive for COVID-19 were obese, but no correlation was noted between obesity and ICU admissions. 75 Finally, an analysis of nationwide data from pediatric cases in Mexico reported that obese children were 39% more likely to have a SARS-CoV-2 infection. 77 The effect of the COVID-19 lockdown policies on weight gain in children is also of concern. A cross-sectional survey of 584 households in the United States reported that families are buying more nonperishable and highly processed foods, and a third of families also reported an increase in their consumption of snack foods and desserts. 80 In a longitudinal study of 41 obese youth in Italy, the intake of food items linked to obesity, such as potato chips, red meat, and sugary drinks had increased significantly while time spent in sports activities had decreased during the first 3 weeks of the national lockdown. 81 The wide disruption in the diet and activities of children due to lockdown policies has the potential to worsen the ongoing obesity epidemic, which in turn places children at greater risk for COVID-19 infection. 82 

As COVID-19 is primarily a respiratory illness, asthma and other respiratory conditions were initially thought to place children at those reporting asthma were not more likely to develop pneumonia, nor were they at higher risk for hospitalization. 77 Surprisingly, an Italian study reported a much lower prevalence of asthma in their pediatric COVID-19 cohort than in the general population (2% vs. 11%). 78 Researchers postulated the potential for asthma to act as a protectant due to adaptation in the immune response of pediatric asthmatics. 78 Behavioral factors may also have contributed to the lower prevalence of pediatric asthmatics among COVID cohorts. Several studies reporting a significant decrease in pediatric asthma-related visits to emergency departments and an increased utilization of telehealth raise the possibility that parents with vulnerable children are being proactive in protecting them against unnecessary exposure to COVID-19. 84,85

Comorbidities involving immunocompromise include organ transplants, malignancies, and aplastic anemia (Table 5) . Notably, some studies used immunocompromised and immunodeficient interchangeably. 18 There was no association between immunosuppressant use and critical care admission. 50 In Mexico, immunodeficiencies were reported in 3.8% (808) of all cases and were associated with a four-fold increase of COVID-19 pneumonia and eight-fold increase in the risk of hospital admission. 77 

In a retrospective study from China, researchers reported that 47.1% a Obesity is defined as BMI (or sex and weight for length percentiles for patients younger than 2) at or above the 95th percentile for age. b Solid organ transplant, hematologic malignancies, solid tumors, hematopoietic stem cell transplant recipient, aplastic anemia. c Study explicitly states or demonstrates the inclusion of asthma in data point for chronic respiratory illness. study participants had co-infections, 16 while in Perú, M. pneumoniae was found in 10% (9/91) of participants. 53 In Latin America, 3.4% (14/409) of participants tested positive for a viral co-infection, although no significant association was found between co-infections and ICU admission or mechanical respiratory support. 22 In contrast, in Europe, 5% (29/582) of participants tested positive for a viral coinfection and patients with one or more viral co-infections were more likely to have signs or symptoms of upper or lower respiratory tract infection at presentation. 18 Individuals with viral co-infection were also significantly more likely to require ICU admission, respiratory support, and vasoactive medications. 18 Overall, there is limited data regarding the presence of viral coinfections within the COVID-19-positive pediatric population.

There is also limited evidence regarding the influence of these coinfections in either increasing a patient's susceptibility to or in contributing to a more severe course of disease. With expected peaks of additional respiratory pathogens like influenza and respiratory syncytial virus during the winter season, we will likely experience the true impact of multiviral respiratory infections in terms of both incidence and clinical severity. prognosis for those children who are diagnosed. 69 In addition, mortality rates remain low. 50, 56, 64, 69 Findings on chronic respiratory illnesses, compromised immunity, and viral co-infections as risk factors for COVID-19 in children are inconclusive, but comorbidities such as obesity are associated with a higher risk of infection and a more severe clinical course of disease. 17, 75, 77, 79 The lower incidence and severity of SARS-CoV-2 infections in children should not allow our focus to shift away from a highly vulnerable population with potential developmental implications. The novelty of COVID-19 has presented many challenges, but there are also unique opportunities to study longitudinally children that have been affected from infancy through childhood and into adulthood.

Continued testing and longer-term investigations are warranted to provide data on risk factors for infection and MIS-C, long-term respiratory and developmental outcomes, as well as behavioral and lifestyle influences. Indeed, such knowledge may assist in framing public policy responses that would protect children and mitigate future epidemics. 

COVID-19 CDC. Response Team. Coronavirus disease 2019 in children -United States

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Korean Society for Antimicrobial Therapy, Korean Society for Healthcareassociated Infection Control and Prevention

Clinical characteristics and viral RNA detection in children With coronavirus disease 2019 in the Republic of Korea

Epidemiology of COVID-19 among children in China

World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

Susceptibility to and transmission of COVID-19 amongst children and adolescents compared with adults: a systematic review and meta-analysis

Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study

Variation in SARS-CoV-2 seroprevalence in school-children across districts, schools and classes

Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening

Racial and/or ethnic and socioeconomic disparities of SARS-CoV-2 infection among children

A comprehensive clinical description of pediatric SARS-CoV-2 infection in Western Pennsylvania. medRxiv

Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate

Closed environments facilitate secondary transmission of coronavirus disease

Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10

Epidemiology, clinical features, and disease severity in patients With coronavirus disease 2019 (COVID-19) in a children's hospital in

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

Characteristics and management of children with COVID-19 in Turkey

SARS-CoV-2 infection in children

Pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): clinical presentation, infectivity, and immune responses

COVID-19 and multisystem inflammatory syndrome in Latin American children: a multinational study

Heavy exposure of children aged 9 to 12 years with SARS-CoV-2 did not lead to infection

Contact tracing during coronavirus disease outbreak

ACE2 expression and activity are enhanced during pregnancy

Vertical transmission risk of SARS-CoV-2 infection in the third trimester: a systematic scoping review

Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China

Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: a living systematic review

SARS-CoV-2 and human milk: what is the evidence?

Detection of SARS-CoV-2 in human breastmilk

Evaluation for SARS-CoV-2 in breast milk from 18 infected women

COVID-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacity

Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review

Adoption of Breastfeeding Recommendations in the Context of COVID-19

Breastfeeding and COVID-19

Holder pasteurization of donated human milk is effective in inactivating SARS-CoV-2

Limited secondary transmission of SARS-CoV-2 in child care programs -Rhode Island

Transmission dynamics of COVID-19 outbreaks associated with child care facilities

Stepwise school opening online and off-line and an impact on the epidemiology of COVID-19 in the pediatric population

SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England

No evidence of secondary transmission of COVID-19 from children attending school in Ireland

Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study

Letter to the editor: COVID-19 cases among school-aged children and school-based measures in Hong Kong

Transmission of SARS-CoV-2 in children aged 0 to 19 years in childcare facilities and schools after their reopening in

Novel coronavirus 2019 transmission risk in educational settings

Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps

A large COVID-19 outbreak in a high school 10 days after schools' reopening, Israel

COVID-19 in Victorian schools: an analysis of child-care and school outbreak data and evidence-based recommendations for opening schools & keeping them open

Public Health Agency of Sweden. COVID-19 in schoolchildren -A comparison between Finland and Sweden

Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

Characteristics and outcomes of children With coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units

Children with Covid-19 in pediatric emergency departments in Italy

Clinical-epidemiological and treatment characteristics of children with COVID-19 in a tertiary referral center in Perú

Clinical characteristics of COVID-19 in children: a systematic review

Children with COVID-19 behaving milder may challenge the public policies: a systematic review and meta-analysis

Multisystem inflammatory syndrome in U.S. children and adolescents

Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children

Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association

Multisystem inflammatory syndrome in children related to COVID-19: a New York City experience

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran

Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic

Guidance -Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS)

Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2

Multisystem inflammatory syndrome in children and adolescents with COVID-19

Centers for Disease Control and Prevention. HAN Archive -00432 | Health Alert Network (HAN). 2020. Available at

Hyperinflammatory shock in children during COVID-19 pandemic

Multisystem inflammatory syndrome associated with COVID-19 in children in Pakistan

COVID-19-associated multisystem inflammatory syndrome in children -United States

Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome

Multisystem inflammatory syndrome in children with COVID-19 in Mumbai

Multisystem inflammatory syndrome in children (MIS-C): report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic

SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study

SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19

Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 at a tertiary care medical center in New York City

Hospitalization rates and characteristics of children aged < 18 years hospitalized with laboratory-confirmed COVID-19 -COVID-NET, 14 states

Obesity and immunodeficiencies are the main preexisting conditions associated with mild to moderate COVID-19 in children

Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019

Obesity predisposes to the risk of higher mortality in young COVID-19 patients

Food insecurity, the home food environment, and parent feeding practices in the era of COVID-19

Effects of COVID-19 lockdown on lifestyle behaviors in children with obesity living in Verona, Italy: a longitudinal study

COVID-19 and obesity in childhood and adolescence: a clinical review

Asthma and COVID-19 in children: a systematic review and call for data

Impact of the COVID-19 pandemic on pediatric emergency department utilization for asthma

2020:AnnalsATS.202007-765RL

Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID-19 pandemic

Clinical outcome of SARS-CoV-2 infection in immunosuppressed children in Spain

Clinical characteristics of 34 children with coronavirus disease-2019 in the west of China: a multiplecenter case series

How to cite this article

COVID-19 in childhood: Transmission, clinical presentation, complications and risk factors

The authors declare that there are no conflict of interests. 

Data sharing not applicable to this article as no data sets were generated or analyzed during the current study.

https://orcid.org/0000-0003-1640-1928Sylvia H. Ley https://orcid.org/0000-0003-0084-2630